(Q46171341)

English

Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor

scientific article published on 7 January 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

Shorter survival-times following adjuvant endocrine therapy in oestrogen- and progesterone-receptor positive breast cancer overexpressing HER2 and/or with an increased expression of vascular endothelial growth factor (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

0 references

progesterone-receptor positive breast cancer

0 references

1 reference

based on heuristic

inferred from title

author name string

B Linderholm

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

J Bergqvist

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

H Hellborg

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

U Johansson

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

M Linderholm

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

E von Schoultz

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

G Elmberger

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

L Skoog

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

J Bergh

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

publication date

7 January 2009

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

26

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

480-490

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

Endocrine therapy of breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-008-9157-9

21 January 2018

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

1 reference

https://api.crossref.org/works/10.1007%2FS12032-008-9157-9

21 January 2018

Clinical implications of circulating angiogenic factors in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of c-erbB-2 is related to a higher expression of vascular endothelial growth factor (VEGF) and constitutes an independent prognostic factor in primary node-positive breast cancer after adjuvant systemic treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation of Vascular Endothelial Growth Factor Content With Recurrences, Survival, and First Relapse Site in Primary Node-Positive Breast Carcinoma After Adjuvant Treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-I

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of VEGF in the reproductive tract by sex-steroid hormones

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Her-2/neu overexpression and response to oophorectomy plus tamoxifen adjuvant therapy in estrogen receptor-positive premenopausal women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HER-2 amplification impedes the antiproliferative effects of hormone therapy in estrogen receptor-positive primary breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

VEGF(165) requires extracellular matrix components to induce mitogenic effects and migratory response in breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progestin regulation of vascular endothelial growth factor in human breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of HER-2 as a resistance mechanism to hormonal therapy for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vascular endothelial growth factor in node-positive breast cancer patients treated with adjuvant tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant letrozole versus tamoxifen according to centrally-assessed ERBB2 status for postmenopausal women with endocrine-responsive early breast cancer: supplementary results from the BIG 1-98 randomised trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of estrogen receptor-mediated gene transcription by IGF-I in human breast cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19130322

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-008-9157-9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19130322

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46171341&oldid=2207693905"